Properties and actions:

Caffeic acid derivatives (mainly chicoric acid), alkamides and polysaccharides are the main active constituent in echinacea, the main of Mulone extract.
Mulone stimulates the immune response by enhancing phagocytosis by macrophages and activation of natural killer cells.
Mulone increases cytokine production, such as interferon which helps in controlling viral infection. Mulone has mild direct antibacterial activity and direct anti-inflammatory activity. Mulone has anti-hyaluronidase enzyme activity which prevents spreading of infection and accelerates recovery. Mulone increases phagocytosis of candida by 45% and decreases the rate of recurrence of fungal infections. Through these actions; Mulone enhances the resistance to viral, bacterial and fungal infections in healthy subjects and shortens the duration of illness and helps in rapid recovery. 


  • Prevention and treatment of common cold and influenza
  • Prophylactic therapy in cases of increased susceptibility to infections
  • Inflammatory skin diseases. Recurrent vaginal candidiasis


(5 - 9years) 

2.5 ml

(1/2 teaspoon)

1-2 times/day
(10 - 14years)
5 ml
(1 teaspoon)
1-2 times/day
Adults & Adolescents
(> 14 years)

10 ml

(2 teaspoons)

1-2 times/day


  • Hypersensitivity to the active substance
  • In accordance with general principles, not to be used in patients with progressive systemic diseases such as tuberculosis, collagenoses, multiple sclerosis, HIV infection and autoimmune diseases. 

Side Effects:

  • In rare cases hypersensitivity reactions, e.g. skin reactions, can occur

Each tablet contains:

  • Echinacea purpurea dry extract 3.75 g (Standardized to contain 3% chicoric acid) 

Pack size:

Bottle of 30 ml drops
Bottle of 60 ml syrup 

Precautions / Drug interactions:

  • Refrigerate after opening & use within 14 days
  • The duration of continuous treatment should not exceed 8 weeks
  • No reported drug interactions